# Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer

> **NCT00059605** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 32 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **GENETIC:** DOTAP:Chol-fus1

## Key facts

- **NCT ID:** NCT00059605
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00059605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00059605, "Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00059605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*